30/11/2009
For the purposes of the Disclosure and Transparency Rules of the
Financial Services Authority, the Board of ReGen is required to
notify the market of the following:
As at the date of this announcement, the Company’s issued share
capital consists of 36,729,882 ordinary shares with a nominal value
of 0.01 p each, with voting rights (“Ordinary Shares”). The Company
does not hold any Ordinary Shares in Treasury.
Therefore the total number of Ordinary Shares in the Company with
voting rights is 36,729,882.
The above figure of 36,729,882 Ordinary Shares may be used by
shareholders in the Company as the denominator for the calculations
by which they will determine if they are required to notify their
interest in, or a change to their interest in, the share capital of
the Company under the Financial Service Authority’s Disclosure and
Transparency Rules.
For further information:
Percy Lomax
ReGen Therapeutics Plc
Tel: 020 7153 4920
Roland Cornish/Felicity Geidt
Beaumont Cornish Limited
Tel: 020 7628 3396